Compound medicine with steroid saponin of Paris polyphylla, method for preparing compound medicine and application thereof

Compound medicine with steroid saponin of Paris polyphylla, method for preparing compound medicine and application thereof

  • CN 105,343,115 A
  • Filed: 11/25/2015
  • Published: 02/24/2016
  • Est. Priority Date: 11/25/2015
  • Status: Active Application
First Claim
Patent Images

1. a Rhizoma Paridis steroidal saponin compound medicine, is characterized in that:

  • comprise active component PSI, PSII and PSV, and its structure is;

    PSI:

    Diosgenin-

    3-

    0-

    α



    L-rhamnopyranosyl-



    l→

    2)[α



    L-arabinofuranosyl-



    1→

    4)]-

    β



    D-glucopyranoside;

    PSⅡ



    Diosgenin-3-0-α

    -L-rhamnopyranosyl-(1→

    4)-α

    -L-rhamnopvranosyl-(1→

    4)-[α

    -L-rhamnopyranosyl-(l→

    2)]-β

    -D-glucopyranoside;

    PSⅤ



    Diosgenin-3-0-α

    -L-rhamnopyranosyl-



    l→

    2)-β

    -D-glucopyranoside。

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×